{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:20:05Z","timestamp":1791148805405,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.contraception.2010.08.012","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T08:21:37Z","timestamp":1286439697000},"page":"229-237","source":"Crossref","is-referenced-by-count":58,"title":["Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients"],"prefix":"10.1016","volume":"83","author":[{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Scarabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Frances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine P.","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Galicier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bl\u00e9try","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gompel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.08.012_bb0005","first-page":"686","article-title":"Pregnancy outcome in women with systemic lupus erythematosus","volume":"63","author":"Gimovsky","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.08.012_bb0010","first-page":"1946","article-title":"Contraception and pregnancy in systemic lupus erythematosus","volume":"40","author":"Gompel","year":"1990","journal-title":"Rev Prat"},{"key":"10.1016\/j.contraception.2010.08.012_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0b013e3181ae9c64","article-title":"Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review","volume":"114","author":"Culwell","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.08.012_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-857X(05)70311-2","article-title":"Hopkins Lupus Pregnancy Center: 1987 to 1996","volume":"23","author":"Petri","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.contraception.2010.08.012_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/art.22480","article-title":"Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study","volume":"57","author":"Costenbader","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.contraception.2010.08.012_bb0030","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s10067-007-0641-y","article-title":"Major flares in women with SLE on combined oral contraception","volume":"26","author":"Whitelaw","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.contraception.2010.08.012_bb0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archinte.145.8.1389","article-title":"Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants","volume":"145","author":"Glueck","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7326\/0003-4819-106-4-524","article-title":"The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level","volume":"106","author":"Petri","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0045","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.08.012_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case\u2013control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.08.012_bb0055","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of an international multicenter case\u2013control study","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.08.012_bb0060","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0065","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/32.3.227","article-title":"Contraceptive practice in women with systemic lupus erythematosus","volume":"32","author":"Julkunen","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.contraception.2010.08.012_bb0075","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.08.012_bb0080","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.08.012_bb0085","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0002-9378(80)91071-6","article-title":"Intrauterine device use and the risk of pelvic inflammatory disease","volume":"138","author":"Burkman","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.08.012_bb0090","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.contraception.2007.01.018","article-title":"The levonorgestrel intrauterine system in nulliparous women","volume":"75","author":"Prager","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.08.012_bb0095","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jcem-51-5-1107","article-title":"Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol","volume":"51","author":"Kuttenn","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.08.012_bb0100","first-page":"45","article-title":"Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. A gynecoendocrine, metabolic and vascular study","volume":"15","author":"Pelissier","year":"1987","journal-title":"Contracept Fertil Sex (Paris)"},{"key":"10.1016\/j.contraception.2010.08.012_bb0105","first-page":"2431","article-title":"Contraceptions in women with contra-indication to estrogen\u2013progestins","volume":"45","author":"Gompel","year":"1995","journal-title":"Rev Prat"},{"key":"10.1016\/j.contraception.2010.08.012_bb0110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.contraception.2010.08.012_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005792-199905000-00002","article-title":"Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center","volume":"78","author":"Huong","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.contraception.2010.08.012_bb0120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/art.1780281108","article-title":"Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate","volume":"28","author":"Jungers","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.contraception.2010.08.012_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/acta.0.1000091","article-title":"The effect of cyproterone acetate on pituitary\u2013ovarian function and clinical symptoms in hirsute women","volume":"100","author":"Lunell","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.contraception.2010.08.012_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-5122(82)90054-8","article-title":"Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa","volume":"4","author":"Wolff","year":"1982","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.08.012_bb0135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.contraception.2010.08.012_bb0140","series-title":"Renal diseases: classification and atlas of glomerular diseases","first-page":"151","article-title":"Lupus nephritis","author":"Churg","year":"1995"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2010.08.012_bb0145","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.08.012_bb0150","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0002-9378(12)90942-4","article-title":"Considerations for contraception in women with cardiovascular disorders","volume":"168","author":"Sullivan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.08.012_bb0155","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199305273282108","article-title":"Hormonal contraception","volume":"328","author":"Baird","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/13625189809167250","volume":"3","year":"1998","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.08.012_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.08.012_bb0170","first-page":"414","article-title":"Depot medroxyprogesterone acetate contraception in women with medical problems","volume":"41","author":"Frederiksen","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0175","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chakhtoura","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.contraception.2010.08.012_bb0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/096120339900800614","article-title":"Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases","volume":"8","author":"Cretel","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.contraception.2010.08.012_bb0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1783\/147118901101195029","article-title":"Contraceptive practices in women with systemic lupus erythematosus and\/or antiphospholipid syndrome: what advice should we be giving?","volume":"27","author":"Lakasing","year":"2001","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.08.012_bb0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/13625189809167250","article-title":"A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms\/day or levonorgestrel 30 micrograms\/day","volume":"3","year":"1998","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.08.012_bb0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.contraception.2005.12.012","article-title":"Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants","volume":"73","author":"Hidalgo","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.08.012_bb0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0010-7824(01)00213-X","article-title":"A 12-month clinical investigation with a 24-day regimen containing 15 microg ethinylestradiol plus 60 microg gestodene with respect to hemostasis and cycle control","volume":"63","author":"Fruzzetti","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.08.012_bb0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5122(03)00194-4","article-title":"Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis\u2013morphometric study","volume":"46","author":"Jondet","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.08.012_bb0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10067-002-8272-9","article-title":"Bone mineral density in women with systemic lupus erythematosus","volume":"21","author":"Bhattoa","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.contraception.2010.08.012_bb0215","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/096120339700600510","article-title":"Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus \u2014 a meta-analysis","volume":"6","author":"Wahl","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.contraception.2010.08.012_bb0220","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humrep\/deg120","article-title":"The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case\u2013control study","volume":"18","author":"Seaman","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.08.012_bb0225","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.08.012_bb0230","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1701-2163(16)30342-5","article-title":"Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation","volume":"25","author":"Spitzer","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2010.08.012_bb0235","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(02)08298-3","article-title":"Risk of venous thromboembolism and oral contraceptives","volume":"359","author":"Gompel","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.08.012_bb0240","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial","volume":"142","author":"Buyon","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0245","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.contraception.2010.08.012_bb0250","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0255","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0260","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2010.08.012_bb0265","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMp038168","article-title":"Systemic lupus erythematosus and accelerated atherosclerosis","volume":"349","author":"Hahn","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.012_bb0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1191\/096120300678828181","article-title":"How accelerated atherosclerosis in SLE has changed our management of the disorder","volume":"9","author":"Hallegua","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.contraception.2010.08.012_bb0275","first-page":"1403","article-title":"Effects of progestatin on glucido-lipid metabolism and coagulation","volume":"31","author":"Basdevant","year":"1981","journal-title":"Rev Prat"},{"key":"10.1016\/j.contraception.2010.08.012_bb0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.contraception.2010.08.012_bb0285","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/art.1780210412","article-title":"Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States","volume":"21","author":"Kaslow","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.contraception.2010.08.012_bb0290","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1056\/NEJMe058269","article-title":"Oral contraceptives in systemic lupus erythematosus \u2014 a tough pill to swallow?","volume":"353","author":"Bermas","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410004750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410004750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T08:47:47Z","timestamp":1559724467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410004750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0010782410004750"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.08.012","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}